Rapid Development of the FDA ACMT COVID-19 ToxIC (FACT) Pharmacovigilance Pilot Project to Monitor Adverse Events Reported in Association with COVID-19 Therapeutics

Saved in:
Bibliographic Details
Published inToxicology letters Vol. 350; p. S20
Main Authors Wax, P.M., Aldy, K., Brent, J.
Format Journal Article
LanguageEnglish
Published Elsevier B.V 01.09.2021
Published by Elsevier B.V. Published by Elsevier B.V
Online AccessGet full text

Cover

More Information
ISSN:0378-4274
1879-3169
DOI:10.1016/S0378-4274(21)00280-0